- Home
- CRDF vs PRPL Comparison
CRDF vs PRPL Comparison
Compare CRDF & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- PRPL
- Stock Information
- Founded
- CRDF 1999
- PRPL 2010
- Country
- CRDF United States
- PRPL United States
- Employees
- CRDF N/A
- PRPL N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- PRPL Home Furnishings
- Sector
- CRDF Health Care
- PRPL Consumer Discretionary
- Exchange
- CRDF Nasdaq
- PRPL Nasdaq
- Market Cap
- CRDF 144.4M
- PRPL 125.6M
- IPO Year
- CRDF N/A
- PRPL N/A
- Fundamental
- Price
- CRDF $2.05
- PRPL $1.05
- Analyst Decision
- CRDF Strong Buy
- PRPL Hold
- Analyst Count
- CRDF 5
- PRPL 1
- Target Price
- CRDF $11.10
- PRPL $1.00
- AVG Volume (30 Days)
- CRDF 1.1M
- PRPL 641.5K
- Earning Date
- CRDF 11-06-2025
- PRPL 11-03-2025
- Dividend Yield
- CRDF N/A
- PRPL N/A
- EPS Growth
- CRDF N/A
- PRPL N/A
- EPS
- CRDF N/A
- PRPL N/A
- Revenue
- CRDF $545,000.00
- PRPL $456,844,000.00
- Revenue This Year
- CRDF N/A
- PRPL N/A
- Revenue Next Year
- CRDF N/A
- PRPL $11.87
- P/E Ratio
- CRDF N/A
- PRPL N/A
- Revenue Growth
- CRDF N/A
- PRPL N/A
- 52 Week Low
- CRDF $1.90
- PRPL $0.56
- 52 Week High
- CRDF $5.64
- PRPL $1.29
- Technical
- Relative Strength Index (RSI)
- CRDF 36.50
- PRPL 51.37
- Support Level
- CRDF $2.03
- PRPL $1.04
- Resistance Level
- CRDF $2.27
- PRPL $1.11
- Average True Range (ATR)
- CRDF 0.12
- PRPL 0.08
- MACD
- CRDF 0.04
- PRPL -0.02
- Stochastic Oscillator
- CRDF 31.91
- PRPL 16.00
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.